Loading company…
Synthetica Pioneering researches live bacterial drugs for solid tumors.
Founded in 2023 and based in Shenzhen, China, Synthetica Pioneering researches and develops live bacterial drugs for solid tumors. It raised Series A funding in July 2024 led by Boehringer Ingelheim Venture Fund. The funding will support advancing its oncolytic bacterial pipelines toward clinical trials.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in